Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-23

FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluphenazine hydrochloride by Lannett, adding another generic version of this antipsychotic to the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

SUPPL AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)